Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results

Go back to Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
(NASDAQ: NAGE) Delayed: 3.21 +0.06 (1.90%)
Previous Close $3.15    52 Week High
Open $3.17    52 Week Low
Day High $3.24    P/E N/A 
Day Low $3.14    EPS
Volume 370,277